Observational Pregnancy Surveillance Program of Patients Exposed to Epidiolex®/Epidyolex® During Pregnancy to Assess the Risk of Pregnancy and Maternal Complications and Other Events of Interest on the Developing Fetus, Neonate, and InfantFirst published 21/11/2023 Last updated 21/11/2023 EU PAS number: EUPAS107705StudyPlanned